Sep / 2025

OncoDaily IO OncoDaily GI Hemostasis Today

24/03/2024

Mar 24, 2024 11:53 pm

Mar 24, 2024 11:44 pm

Mar 24, 2024 11:38 pm

Mar 24, 2024 11:26 pm

Mar 24, 2024 11:14 pm

Mar 24, 2024 1:54 pm

Mar 24, 2024 1:47 pm

Mar 24, 2024 1:42 pm

Mar 24, 2024 1:32 pm

Mar 24, 2024 1:10 pm

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

24/03/2024

Peter Pisters: I enjoyed sharing my personal learnings and reflections as I transitioned from the operating room to the board room for the SSO2024

Karima Oualla: Delighted to be among impactful women in healthcare in Morocco 2024

EORTC review analyzes the critical aspects of patient involvement in oncology trials, highlighting the key elements for meaningful collaborations

Jarushka Naidoo: ESMO Young Oncologists (YO) session on career navigation with ⁦Herbert Loong, Lizza Hendriks, Alfredo Addeo & I

FDA Oncology: FDA Oncology’s Dan Suzman discusses approaches to oncology trials and regulatory issues

Naveen Pemmaraju: Delighted to share my interview and discussion with Dr Neil Love on BPDCN

Jean-Charles Soria: Thank you to my American Association for Cancer Research colleagues for this humbling vote of confidence

Chris Chukwunyere: Driving Collaboration for Enhanced Cancer Care in Abuja

Arif Kamal: There’s an urgency of now in patient navigation

MiNK Therapeutics announced results for the fourth quarter and year-end of 2023

Headlines

24/03/2024

Peter Pisters: I enjoyed sharing my personal learnings and reflections as I transitioned from the operating room to the board room for the SSO2024

Karima Oualla: Delighted to be among impactful women in healthcare in Morocco 2024

EORTC review analyzes the critical aspects of patient involvement in oncology trials, highlighting the key elements for meaningful collaborations

Jarushka Naidoo: ESMO Young Oncologists (YO) session on career navigation with ⁦Herbert Loong, Lizza Hendriks, Alfredo Addeo & I

FDA Oncology: FDA Oncology’s Dan Suzman discusses approaches to oncology trials and regulatory issues

Naveen Pemmaraju: Delighted to share my interview and discussion with Dr Neil Love on BPDCN

Jean-Charles Soria: Thank you to my American Association for Cancer Research colleagues for this humbling vote of confidence

Chris Chukwunyere: Driving Collaboration for Enhanced Cancer Care in Abuja

Arif Kamal: There’s an urgency of now in patient navigation

MiNK Therapeutics announced results for the fourth quarter and year-end of 2023

Headlines

OncoDaily

Oncology

cancer

fight against cancer

Global fight against cancer

cancer care

Breast Cancer

ASCO

Lung cancer

Cancer research

MD Anderson Cancer Center

cancer awareness

NSCLC

ESMO

immunotherapy

cancer treatment

Research

ASCO24

Headlines

colorectal cancer

Childhood Cancer

prostate cancer

AACR

clinical trials

FDA

Dana-Farber Cancer Institute

UICC

American Cancer Society

European Cancer Organisation

NCI

National Cancer Institute

healthcare

SIOP

ASCO25

chemotherapy

Vivek Subbiah

AI

American Society of Clinical Oncology

Paolo Tarantino

IASLC

WHO

Robert Orlowski

multiple myeloma

Memorial Sloan Kettering Cancer Center

Zainab Shinkafi-Bagudu

radiation oncology

Myeloma Paper of the Day

cervical cancer

Myeloma

patient care

European School of Oncology

Sitemap